Synthetic Genomics, Inc. (SGI) has appointed Aaron Hanson as Vice President, Operations of its SGI-DNA subsidiary. SGI-DNA, founded in 2013 and headquartered in La Jolla, CA, provides differentiated synthetic DNA solutions to leading organizations with demands for large and/or complex DNA constructs.
Prior to joining SGI-DNA, Hanson served as Director of Manufacturing at Alere. From 2008-2010, he served as Director of Manufacturing at Illumina, Inc. Previously, Hanson served as Senior Manager of Manufacturing at Invitrogen Corporation. In earlier roles, he served as Senior Scientist and Group Leader of Product Development and Process Chemistry at Sequenom, Inc. where he also served as Scientist.
Hanson received his Ph.D. in Pharmaceutical Sciences and Medicinal Chemistry from the University of Nebraska Medical Center. He received his B.A. in Biology and Chemistry from Point Loma Nazarene College.
About Synthetic Genomics, Inc.
SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing new synthetic DNA products and technologies through SGI-DNA, algae biofuels, new and improved food and nutritional products, and clean water technology. SGI is also involved in synthetically derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a business unit co-founded with the J. Craig Venter Institute; and in developing sustainable crops such as castor and sweet sorghum and agricultural products through AgraCast, a company cofounded with Plenus S.A. de C.V. For more information go to: www.syntheticgenomics.com.